Jefferies analyst Faisal Khurshid initiates coverage on Insmed (NASDAQ: INSM) with a Buy rating and a price target of $228.00.

For an analyst ratings summary and ratings history on Insmed click here. For more ratings news on Insmed click here.

Shares of Insmed closed at $139.50 yesterday.